🇺🇸 FDA
Patent

US 9206240

Pseudomonas exotoxin A with less immunogenic B cell epitopes

granted A61KA61K38/00A61K38/164

Quick answer

US patent 9206240 (Pseudomonas exotoxin A with less immunogenic B cell epitopes) held by The United States of America,as represented by the Secretary,Department of Helath and Human Services expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America,as represented by the Secretary,Department of Helath and Human Services
Grant date
Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61K38/164, A61K47/6829, A61P